|
Press Releases
|
TimTec Expands Partnership With Collaborative Drug Discovery Through Publishing Three Additional Libraries on CDD's Free Public Access Database
Last October, TimTec and Collaborative Drug Discovery (CDD) established a collaboration in which CDD's web-based data management system would host two TimTec Natural Products libraries on their free community Public Access site. Through this partnership, researchers would be able to register for a free account with CDD allowing them to chemically mine the contents of these TimTec compound libraries using CDD's powerful, intuitive web-based database software.
TimTec is now offering three more libraries on the CDD Public Access database:
The TimTec ActiTarg-K Kinase Modulators library contains over 6,000 compounds known to inhibit protein kinase activity:
The TimTec OGT Inhibitors Analogs library contains more than 300 compounds analogous to three known O-GlcNAc Transferase inhibiting molecules:
Finally, the TimTec resourceful Diversity Set is a general screening collection of drug-like compounds that present most diversified selection from TimTec stock. This screening library contains 10,000 of the most diverse compounds, all complying with the Lipinski Rule of Five:
TimTec's five databases join more than 25 other databases containing chemical and biological data hosted on CDD Public Access, including:
47,000 Ki values for 20,000 compounds against 699 GPCR targets from the NIMH Psychoactive Drug Screening Program at the University of North Carolina
Over 15,000 compounds with Malaria assay data from 5 public data sources
48,818 compounds from the Distributed Drug Discovery (D3) at Indiana University – Purdue University Indianapolis (IUPUI)
Almost 7,500 compounds with Tuberculosis antibacterial and cell viability information from 4 public data sets and growing thanks to their collaboration with the Bill & Melinda Gates Foundation
About TimTec, LLC.
TimTec LLC. - http://www.timtec.net - is a privately held company located in Newark Delaware, USA. It was founded in 1995 and began its work in the areas of acquisition and distribution of synthetic organic and natural compounds, custom synthesis, and laboratory equipment to become a full service partner for drug discovery. TimTec has established a global network of thousands of scientists from research centers around the world. The company has developed strong in-house expertise assembling general and targeted library collections for variety of research purposes. International customers include major pharmaceutical, biotech, agricultural, and educational companies and institutions, which use TimTec products for research and development programs.
For more information on TimTec library collections, please contact:
Kay Denisova
Business Development
TimTec LLC
Harmony Business Park Building 301-A
Newark, DE 19711
Tel 302 292 8500
Fax 302 292 8520
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
http://www.timtec.net
About Collaborative Drug Discovery, Inc.
Collaborative Drug Discovery, Inc. (CDD) - http://www.collaborativedrug.com - provides web-based software that organizes preclinical research data to help scientists advance new drug candidates more effectively. The CDD database enables scientists to “archive, mine, and collaborate”® around preclinical chemical and biological drug discovery data through a web-based interface. The software helps distributed research groups to safely store and intelligently analyze small molecule, enzyme, cell and animal bioactivity data accumulated from both low-throughput and high-throughput screens. Unique collaboration features and CDD’s community-oriented approach help unite globally dispersed humanitarian efforts against neglected infectious diseases. Similar collaborative strategies are also rapidly gaining prominence in the commercial arena. CDD offers its industrial-strength database software at a price affordable to academic laboratories, research foundations, and small companies.
For further information please contact:
Barry Bunin, PhD
President & CEO
Collaborative Drug Discovery (CDD)
1633 Bayshore Hwy, Suite 342
Burlingame, CA 94010
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
Drug Discovery News
-
Alzheimer’s Study Leads To Better Drug For Infections
Research into Alzheimer’s disease seems an unlikely approach to yield a better way to fight urinary tract infections (UTIs), but that’s what scientists at Washington University School of Medicine in St. Louis and elsewhere recently reported.
One element links the disparate areas of research: amyloids, which are fibrous, sticky protein aggregates. [...]
-
University of California, San Francisco, Researcher Receives ASBMB-Merck Award
Bethesda, MD, December 12, 2009 –(PR.com)– James A. Wells, professor and chairman of the department pharmaceutical chemistry at the University of California, San Francisco, and director of UCSF’s small molecule discovery center, has been named the winner of the 2010 American Society for Biochemistry and Molecular Biology-Merck Award for his [...]
-
Techne accelerates sample concentration
The Techne Sample Concentrator provides fast solvent or diluent evaporation without sample loss when used with one of the company’s Dri-Block heaters.
The height-adjustable head of the concentrator delivers a flow of inert gas that removes evaporated solvent from the surface of solutions in tubes or 96-well plates.
Traditional methods of reducing [...]
-
Potent Novel Tool For Combating Autoimmune Diseases And Leukemia
A study carried out by the scientists at the Scripps Research Institute illustrated a novel, highly practical strategy for identifying molecules that avert a particular form of immune cells from launching assaults on their host. These findings have added a potent new-fangled tool to the ongoing investigation for probable treatments [...]
-
Karwar scientist’s theory to ‘weed’ out CO2
KARWAR: While representatives of 192 countries are engaged in climate change debates at Copenhagen, Dr Ullas Naik, a marine scientist at the department of marine biology, at Karnatak University’s PG Centre, here has suggested the unassuming sea weed as a possible cure to the planet’s ills.Calling for the scientific culture [...]
-
Hi-tech microscopes make androgen therapy ‘personal’
HOUSTON — (December 9, 2009) — On rare occasions, an infant is born with outward appearance of a female but the XY chromosomes of a male. If the child has a normal Y chromosome — the chromosome responsible for testicular development — the condition is known as androgen insensitivity syndrome.
Experts estimate [...]
-
2009: The Year That Was For Pfizer
(RTTNews) - True to expectations, Jeffrey Kindler, the CEO of Pfizer Inc. (PFE | Quote | Chart | News | PowerRating), scripted a new playbook for the drug giant in 2009, accelerating the process of transformation by clinching the largest pharmaceutical [...]
-
Model for powerful flu fighters from existing drugs
Computer compatibility tests might help flu-fighting drugs find their groove.
A pandemic of the H1N1 swine flu virus has health officials worried that the virus could develop resistance to drugs such as Tamiflu used to treat infected people. A new computerized screening method could help find new or already existing drugs that [...]
-
Therasis Obtains $12 Million From Tilocor in Series A Round
GA_googleCreateDomIframe(’google_ads_div_Press336′ ,’Press336′);
GA_googleFillSlot(”Press160″);
GA_googleCreateDomIframe(’google_ads_div_Press160′ ,’Press160′);
NEW YORK, NY — 12/08/09 [...]
-
InformexUSA 2010
InformexUSA has become the leading resource for buyers and sellers of high-value chemistry for a broad range of applications. Today’s pharmaceutical innovators, agrochemical product makers, electronic materials producers and other manufacturers that come to Informex find what they need for business success: mainly new ideas that make a difference, and qualified companies with production assets [...]
|
|
|
|
Call toll free 1 800 574 7391
|
